Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer

Clinical trial NCT00842257 · COMPLETED

Trial details

NCT number: NCT00842257
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2009-05-01
Primary completion: 2011-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.